Your browser doesn't support javascript.
loading
Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms.
Sigurðsson, Haraldur H; Olesen, Christina W; Dybboe, Rie; Lauritzen, Gitte; Pedersen, Stine F.
Afiliação
  • Sigurðsson HH; Department of Biology, Section for Cell and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.
  • Olesen CW; Department of Biology, Section for Cell and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.
  • Dybboe R; Department of Biology, Section for Cell and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.
  • Lauritzen G; Department of Biology, Section for Cell and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen SF; Department of Biology, Section for Cell and Developmental Biology, University of Copenhagen, Copenhagen, Denmark. sfpedersen@bio.ku.dk.
Mol Cancer Res ; 13(1): 63-77, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25143433
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Cisplatino / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Cisplatino / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article